The private equity owners of Stada are close to mandating investment banks to sell the German generic drugmaker or list it on the stock exchange, newspaper Handelsblatt reported on Wednesday, citing financial sources.
The company, majority-owned (since 2017) by buyout firms Bain and Cinven, who you can meet at the UK Private Equity Conference, sells consumer healthcare products such as painkillers and sunscreen lotions, as well as biosimilar and generic drugs, which are cheaper copies of established pharmaceuticals that have lost patent protection.
Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Stada declined to comment. A spokesperson for Cinven could not immediately be reached for comment.
The Handelsblatt report said the most likely option for now was the sale of a minority stake in Stada to a third investor, and said Stada could be valued at up to 15bn euros ($16.10 bn) in a transaction.
Source: Yahoo! Finance
Can’t stop reading? Read more
Apollo expands clean energy footprint with $6.5bn stake in Ørsted’s Hornsea 3 wind farm
Apollo expands clean energy footprint with $6.5bn stake in Ørsted’s Hornsea 3 wind farm Apollo...
Starbucks offloads 60% of China arm to Boyu Capital in $4bn transaction
Starbucks offloads 60% of China arm to Boyu Capital in $4bn transaction Starbucks has agreed to...
Ares posts strong Q3 results with record fundraising and 28% AUM growth
Ares posts strong Q3 results with record fundraising and 28% AUM growth Ares Management...